| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.021 | 11.540 | - | 0 | 0 | 331 | 0 | 909 | 329 | 719 |
| Total Income - EUR | 4.021 | 11.540 | - | 0 | 0 | 331 | 0 | 909 | 329 | 719 |
| Total Expenses - EUR | 1.547 | 4.199 | - | 281 | 303 | 355 | 552 | 4.626 | 887 | 1.617 |
| Gross Profit/Loss - EUR | 2.474 | 7.341 | - | -281 | -303 | -24 | -552 | -3.716 | -559 | -899 |
| Net Profit/Loss - EUR | 2.353 | 6.994 | - | -281 | -303 | -34 | -552 | -3.743 | -559 | -899 |
| Employees | 1 | 1 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermamed Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 948 | 1.365 | - | 756 | 466 | 258 | 154 | 57 | 0 | 0 |
| Current Assets | 1.575 | 8.107 | - | 10.795 | 10.558 | 10.523 | 9.835 | 2.420 | 3.059 | 1.843 |
| Inventories | 1.106 | 0 | - | 0 | 0 | 0 | 20 | 217 | 641 | 669 |
| Receivables | 0 | 0 | - | 0 | 0 | 0 | 0 | 142 | 35 | 30 |
| Cash | 470 | 8.107 | - | 10.795 | 10.558 | 10.523 | 9.815 | 2.061 | 2.382 | 1.144 |
| Shareholders Funds | 2.398 | 9.368 | - | 11.550 | 11.024 | 10.781 | 9.990 | 194 | -366 | -1.262 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 125 | 104 | - | 0 | 0 | 0 | 0 | 2.283 | 3.425 | 3.106 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermamed Plus Srl